ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 675,68
1,18%
DAX
18 001,60
0,54%
Brent Oil
82,765
0,00%
Bitcoin
63 596,40
1,12%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. USOTC
  6. Axim Biotechnologies Inc (QB) (AXIM)

  7. Axim Biotechnologies Inc (QB) (AXIM) Actualités

AXIM

Axim Biotechnologies (QB) (AXIM)

Axim Biotechnologies Inc (QB)
De:
Trier par:
 Showing the most relevant articles for your search:USOTC:AXIM
DateHeureSourceTitreSymboleSociété
28/12/202317h59Edgar (US Regulatory)Form 8-K - Current reportUSOTC:AXIMAxim Biotechnologies Inc (QB)
20/11/202322h29Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:AXIMAxim Biotechnologies Inc (QB)
21/09/202317h07Edgar (US Regulatory)Form DEF 14C - Other definitive information statementsUSOTC:AXIMAxim Biotechnologies Inc (QB)
31/08/202322h10Edgar (US Regulatory)Form PRE 14C - Other preliminary information statementsUSOTC:AXIMAxim Biotechnologies Inc (QB)
14/08/202322h11Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBUSOTC:AXIMAxim Biotechnologies Inc (QB)
12/06/202312h43Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:AXIMAxim Biotechnologies Inc (QB)
30/05/202321h51Edgar (US Regulatory)Current Report Filing (8-k)USOTC:AXIMAxim Biotechnologies Inc (QB)
22/05/202323h02Edgar (US Regulatory)Quarterly Report (10-q)USOTC:AXIMAxim Biotechnologies Inc (QB)
17/04/202322h46Edgar (US Regulatory)Annual Report (10-k)USOTC:AXIMAxim Biotechnologies Inc (QB)
31/03/202312h04Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)USOTC:AXIMAxim Biotechnologies Inc (QB)
07/10/202221h28Edgar (US Regulatory)Report of Proposed Sale of Securities (144)USOTC:AXIMAxim Biotechnologies Inc (QB)
24/09/202200h06Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:AXIMAxim Biotechnologies Inc (QB)
23/09/202222h08Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)USOTC:AXIMAxim Biotechnologies Inc (QB)
23/09/202222h06Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:AXIMAxim Biotechnologies Inc (QB)
31/08/202222h08Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)USOTC:AXIMAxim Biotechnologies Inc (QB)
16/08/202212h07Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:AXIMAxim Biotechnologies Inc (QB)
02/08/202212h07Edgar (US Regulatory)Securities Registration Statement (s-1/a)USOTC:AXIMAxim Biotechnologies Inc (QB)
25/07/202213h12Edgar (US Regulatory)Securities Registration Statement (s-1)USOTC:AXIMAxim Biotechnologies Inc (QB)
19/04/202223h26Edgar (US Regulatory)Amended Annual Report (10-k/a)USOTC:AXIMAxim Biotechnologies Inc (QB)
02/06/202112h01Edgar (US Regulatory)Amended Quarterly Report (10-q/a)USOTC:AXIMAxim Biotechnologies Inc (QB)
17/12/201912h02Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)USOTC:AXIMAxim Biotechnologies Inc (QB)
13/09/201814h45InvestorWireThe CBD Bonanza on the HorizonUSOTC:AXIMAxim Biotechnologies Inc (QB)
21/05/201812h21Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)USOTC:AXIMAxim Biotechnologies Inc (QB)
13/12/201714h45InvestorWireDangerous Opioid Side Effects Shift Market Focus to Cannabis for Chronic PainUSOTC:AXIMAxim Biotechnologies Inc (QB)
06/12/201714h45InvestorWireAdvanced Biosynthesis Setting New Standards for Cannabinoid-based Pain ManagementUSOTC:AXIMAxim Biotechnologies Inc (QB)
07/11/201714h45InvestorWireBiotech M&A Momentum Attractive for Cannabinoid R&D SpaceUSOTC:AXIMAxim Biotechnologies Inc (QB)
25/10/201714h45InvestorWireBiotechs Develop Proprietary Systems to Drive CBD Research and DevelopmentUSOTC:AXIMAxim Biotechnologies Inc (QB)
28/09/201714h45InvestorWireCannabinoid Biosynthesis Poised as Potential Game-Changer in Drug DevelopmentUSOTC:AXIMAxim Biotechnologies Inc (QB)
26/09/201714h45InvestorWireMedical Cannabis Companies Leverage Biosynthesis to Boost Drug DevelopmentUSOTC:AXIMAxim Biotechnologies Inc (QB)
13/09/201714h45InvestorWireBiosynthesis Technology Could Transform Cannabinoid ProductionUSOTC:AXIMAxim Biotechnologies Inc (QB)
 Showing the most relevant articles for your search:USOTC:AXIM

Dernières Valeurs Consultées

NYSE
KO
Coca Cola
EU
EN
Bouygues
EU
BEL20
Bel 20
NASDAQ
NVDA
NVIDIA
EU
VK
Vallourec
USI
USTECH100
US Tech 100
EU
ACA
Credit Agricole
EU
BN
Danone
EU
RNO
Renault
NYSE
MRK
Merck
COIN
ETHUSD
Ethereum
EU
AF
Air FranceKLM
FTSE
UKX
FTSE 100
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés